A Single-arm, Dose-escalation and Dose-expansion Phase I Clinical Study to Evaluate the Tolerability, Safety and Preliminary Efficacy of BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children

Study Summary

This is a single-arm, single-dose dose-escalation and dose-expansion study.

Interventions

Study Locations

No locations listed.

Official Trial Information